https://journals.umt.edu.pk/index.php/CPR/issue/feed Currents in Pharmaceutical Research 2025-09-30T04:08:30+00:00 Prof. Dr. Ejaz Ullah Cheema [email protected] Open Journal Systems <p>Currents in Pharmaceutical Research (CPR) is an International open access peer-reviewed journal that aims to publish high-quality research in the field of pharmaceutical sciences. The journal welcomes contributions from researchers worldwide and encourages interdisciplinary approaches that integrate pharmaceutical science with other related fields. The journal aims to be a valuable resource for the pharmaceutical industry, regulatory bodies, and healthcare professionals seeking to enhance their understanding of drug development, evaluation, and use.</p> https://journals.umt.edu.pk/index.php/CPR/article/view/6847 Publication Bias: A Brief Concept Note 2025-04-22T11:35:29+00:00 Muhammad Ali [email protected] 2025-04-22T10:56:35+00:00 Copyright (c) 2025 Currents in Pharmaceutical Research https://journals.umt.edu.pk/index.php/CPR/article/view/6574 Cubosomes in Drug Delivery: Exploring Their Potential for Advanced Therapeutic Applications 2025-04-22T10:42:09+00:00 Saman Ali [email protected] Nouman Farooq [email protected] Sabi Ur Rehman [email protected] Fazal Ur Rehman [email protected] <p>Cubosomes have become a subject of increasing significance because of their unique three-dimensional nano cubic lattice structure, which is composed of self-assembling lipid molecules like monoolein. A wide range of therapeutic agents, involving both hydrophilic and hydrophobic drugs, can be encapsulated within this stable and water-dispersible structure. Cubosomes' unique cubic lattice also facilitates surface modifications and lipid content adaptation, improving drug stability and resistance to degradation. This enables precise control over the kinetics of drug release and provides an intriguing framework for the development of controlled drug release systems. As a result, cubosomes can improve therapeutic efficacy while minimizing side effects of drugs molecules. In conclusion, this review explores the potential uses of cubosomes and highlights the specifics that emphasize their significance in improving drug delivery methods.</p> 2025-04-12T00:00:00+00:00 Copyright (c) 2025 Currents in Pharmaceutical Research https://journals.umt.edu.pk/index.php/CPR/article/view/7261 Cost-Effectiveness Analysis of Antihypertensive Medications Prescribed to Primary Hypertension Patients at District Headquarters Hospital, Kohat 2025-09-30T04:08:30+00:00 Marvi Shaheen [email protected] Sajid Khan Sadozai [email protected] Rooh Ullah [email protected] Sajid Hussain [email protected] Fawad Ali [email protected] Majid Khan Sadozai [email protected] Farina Kanwal [email protected] Naveed Safdar [email protected] <p>Hypertension, a major risk factor for cardiovascular diseases (CVDs), contributes to 9.3 million deaths annually. In low- and middle-income countries (LMICs) like Pakistan, cost-effective treatment is critical due to limited healthcare resources. This study aimed to evaluate the cost-effectiveness of antihypertensive medications prescribed to patients with primary hypertension at the District Headquarters (DHQ) Hospital, KDA, Kohat in the Khyber Pakhtunkhwa province of Pakistan. A cross-sectional retrospective study was conducted over a period of six months, involving 320 patients (55.31% male, 44.69% female) aged 18-60 years. Prescription patterns and costs of antihypertensive medications (monotherapy and combination therapy) were analyzed using hospital records. The total cost of prescribed antihypertensive medications was PKR 261,153.00, with monotherapy accounting for PKR 208170.00 and combination therapy accounting for PKR 52983.00. Among monotherapies, calcium channel blockers (CCBs) were the most frequently prescribed (107 prescriptions) and accounted for the highest cost (PKR 132114.00, 50.58%), followed by angiotensin receptor blockers (ARBs) (PKR 37238.00, 14.25%). In contrast, diuretics were the most cost-effective option, costing only PKR 25.2 per unit dose. For combination therapy, amlodipine + hydrochlorothiazide combination was the most prescribed, while losartan + amlodipine combination incurred the highest cost. Monotherapy was prescribed in 67.18% of cases, with most patients showing a positive response before transitioning to combination therapy. CCBs and diuretics were found to be more cost-effective, whereas ACE inhibitors were among the most expensive options. CCBs were the most frequently prescribed in monotherapy, while the combination of amlodipine and atenolol was commonly used in multidrug regimens. The current study highlights the importance of considering patients’ socioeconomic status when initiating pharmacologic treatment. Cost-effective prescribing is crucial in the resource-limited settings of Pakistan, where balancing clinical efficacy and affordability is essential. The findings support WHO recommendations for the rational use of combination therapy and emphasize the use of low-cost medications to optimize treatment outcomes in low- and middle-income countries.</p> 2025-09-29T11:18:53+00:00 Copyright (c) 2025 Marvi Shaheen, Sajid Khan Sadozai, Rooh Ullah, Sajid Hussain, Fawad Ali, Majid Khan Sadozai, Farina Kanwal, Naveed Safdar